EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSJJAG00000024276
Gene Symbol: PRMT5
3 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSJJAG00000019799
Gene Symbol: PRKCA
3 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSJJAG00000005803
Gene Symbol: PRKCB
3 Cross references
284 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSJJAG00000018835
Gene Symbol: PRKCD
3 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSJJAG00000011942
Gene Symbol: PRKCE
3 Cross references
315 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSJJAG00000020392
Gene Symbol: PRKCH
3 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSJJAG00000008261
Gene Symbol: PRKCG
3 Cross references
199 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSJJAG00000023257
Gene Symbol: PRKCI
3 Cross references
193 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSJJAG00000011158
Gene Symbol: PRKCQ
3 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSJJAG00000017774
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSJJAG00000021089
Gene Symbol: PRKD3
3 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSJJAG00000021581
Gene Symbol: PRKACA
3 Cross references
283 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).